Medidata Blog

Risk-Based Monitoring: The Challenges and Benefits of Adopting a Strategic Approach

Reading Time: < 1 minute

Lori Convy is the monitoring subject matter expert at Sanofi Pharmaceuticals and participated in the 2013 European Medidata user Group (E-MUG) site management and monitoring panel discussion on the implications of the Transcelerate risk-based monitoring position paper. Held in Florence, Italy, the E-MUG panel discussion also included INC Research's senior director of clinical innovation Jill Collins, Bayer Healthcare's head of business intelligence and oversight Miguel Valenzuela and Medidata's senior product director Steve Young.

In this video, Medidata's Claribel Pichardo chats with Lori about her E-MUG highlights, and the challenges and benefits of implementing a risk-based monitoring program.

Lori Convy is an assistant director at Sanofi working in the global clinical study unit. She's responsible for the implementation of risk-based monitoring.

Jacob Angevine